Ocugen, Inc. — Director's Dealing 2021

Dec 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-12-16

Reporting Person: Fernandes Prabhavathi (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-16	Option (Right to Buy)	$5.02	A	16335	Acquired	2031-12-16	Common Stock (16335)	Direct

Footnotes

F1: The option vests monthly in equal installments over three years commencing on January 16, 2022, subject to continued service with Ocugen, Inc. on the applicable vesting dates.